A randomized, double-masked, sham-controlled phase 3b/4 study of the efficacy, safety, and tolerability of intravitreal aflibercept monotherapy compared to aflibercept with adjunctive photodynamic therapy as indicated in subjects with polypoidal choroidal vasculopathy (PLANET)

Woman and Man

| Country :
| organs :
| Specialty :

Extract

To collect data reflecting the efficacy and safety of aflibercept with and without photodynamic therapy rescue treatment in subjects diagnosed with the polypoidal choroidal vasculopathy subtype of wet age-related macular degeneration. To explore whether intravitreally administered aflibercept monotherapy is non-inferior to that of aflibercept plus photodynamic therapy (as indicated) based upon best-corrected visual acuity in subjects diagnosed with the polypoidal choroidal vasculopathy subtype of age-related macular degeneration.

Inclusion criteria

Polypoidal choroidal vasculopathy (PCV)

Kusajili – Clinical trials directory

A randomized, double-masked, sham-controlled phase 3b/4 study of the efficacy, safety, and tolerability of intravitreal aflibercept monotherapy compared to aflibercept with adjunctive photodynamic the...